Stinnett AA - Search Results

1

Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis.

Stinnett AA, Mullahy J. Stinnett AA, et al. Med Decis Making. 1998 Apr-Jun;18(2 Suppl):S68-80. doi: 10.1177/0272989X98018002S09. Med Decis Making. 1998. PMID: 9566468

2

The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C viral infection in the United States.

Arguedas MR, Heudebert GR, Fallon MB, Stinnett AA. Arguedas MR, et al. Among authors: stinnett aa. Am J Gastroenterol. 2002 Mar;97(3):721-8. doi: 10.1111/j.1572-0241.2002.05554.x. Am J Gastroenterol. 2002. PMID: 11922569

3

Is it really so bad to be unambiguously inefficient? The role of dominance in stochastic cost-effectiveness analysis.

Stinnett AA. Stinnett AA. Med Decis Making. 1999 Jan-Mar;19(1):102-3. doi: 10.1177/0272989X9901900115. Med Decis Making. 1999. PMID: 9917028 No abstract available.

4

The negative side of cost-effectiveness analysis.

Stinnett AA, Mullahy J. Stinnett AA, et al. JAMA. 1997 Jun 25;277(24):1931-2; author reply 1932-3. JAMA. 1997. PMID: 9200628 No abstract available.

5

At what price significance? The effect of price estimates on statistical inference in economic evaluation.

Rittenhouse BE, Dulisse B, Stinnett AA. Rittenhouse BE, et al. Among authors: stinnett aa. Health Econ. 1999 May;8(3):213-9. doi: 10.1002/(sici)1099-1050(199905)8:3<213::aid-hec429>3.0.co;2-o. Health Econ. 1999. PMID: 10348416

6

Ratio-based and net benefit-based approaches to health care resource allocation: proofs of optimality and equivalence.

Laska EM, Meisner M, Siegel C, Stinnett AA. Laska EM, et al. Among authors: stinnett aa. Health Econ. 1999 Mar;8(2):171-4. doi: 10.1002/(sici)1099-1050(199903)8:2<171::aid-hec424>3.0.co;2-e. Health Econ. 1999. PMID: 10342730

7

Estimating CE ratios under second-order uncertainty: the mean ratio versus the ratio of means.

Stinnett AA, Paltiel AD. Stinnett AA, et al. Med Decis Making. 1997 Oct-Dec;17(4):483-9. doi: 10.1177/0272989X9701700414. Med Decis Making. 1997. PMID: 9343807

8

Biliary stents in malignant obstructive jaundice due to pancreatic carcinoma: a cost-effectiveness analysis.

Arguedas MR, Heudebert GH, Stinnett AA, Wilcox CM. Arguedas MR, et al. Among authors: stinnett aa. Am J Gastroenterol. 2002 Apr;97(4):898-904. doi: 10.1111/j.1572-0241.2002.05606.x. Am J Gastroenterol. 2002. PMID: 12003425

9

Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics.

Prosser LA, Stinnett AA, Goldman PA, Williams LW, Hunink MG, Goldman L, Weinstein MC. Prosser LA, et al. Among authors: stinnett aa. Ann Intern Med. 2000 May 16;132(10):769-79. doi: 10.7326/0003-4819-132-10-200005160-00002. Ann Intern Med. 2000. PMID: 10819699

10

An economic evaluation of levofloxacin versus cefuroxime axetil in the outpatient treatment of adults with community-acquired pneumonia.

Rittenhouse BE, Stinnett AA, Dulisse B, Henke CJ, Potter L, Parasuraman B, Martens LL, Williams RR, Kojak C. Rittenhouse BE, et al. Among authors: stinnett aa. Am J Manag Care. 2000 Mar;6(3):381-9. Am J Manag Care. 2000. PMID: 10977438 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results